Filtered By:
Drug: Methylprednisolone
Countries: India Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 26 results found since Jan 2013.
Post ‐infectious cerebellar ataxia following COVID‐19 in a patient with epilepsy
ConclusionPost-infectious cerebellar ataxia is an unusual presentation after COVID-19. The clinician should be aware of such complications following COVID-19 infection as early diagnosis and proper management leads to better outcomes in many patients.
Source: Clinical and Experimental Neuroimmunology - May 2, 2022 Category: Neurology Authors: Sidhartha Chattopadhyay,
Judhajit Sengupta,
Sagar Basu Tags: CASE REPORT Source Type: research
Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India
CONCLUSION: Out of the 50 patients under study, 78% had Covid-19 disease. The primary risk factor of Mucor in patients of Covid-19 was Diabetes Mellitus (84%) with known diabetics (52%) having uncontrolled hyperglycemia (54%) and those who required oxygen support (home/ hospital) (32%). Mucor was more common in males (58%) of age 40 years and above (80%). About 96% of these patients were not vaccinated against Covid-19, and only 42% had a history of Hypertension. Dexamethasone was used in 46% of the patients admitted and 82% were discharged with satisfactory recovery.PMID:35443512
Source: Journal of the Association of Physicians of India - April 21, 2022 Category: General Medicine Authors: Ghayas Ansari A Hamid Ashraf Husaini S HaiderMehdi Source Type: research
